{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:01:28Z","timestamp":1791489688807,"version":"4.3.4"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T00:00:00Z","timestamp":1527465600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P24186-B21"],"award-info":[{"award-number":["P24186-B21"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00267","type":"journal-article","created":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T04:17:53Z","timestamp":1527481073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":156,"title":["Physiological Actions of Fibroblast Growth Factor-23"],"prefix":"10.3389","volume":"9","author":[{"given":"Reinhold G.","family":"Erben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","year":"2000","journal-title":"Nat Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jbmr.5650040407","article-title":"Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice","volume":"4","author":"Meyer","year":"1989","journal-title":"J Bone Miner Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fendo.2015.00154","article-title":"Endocrine FGFs: evolution, physiology, pathophysiology, and pharmacotherapy","volume":"6","author":"Itoh","year":"2015","journal-title":"Front Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the Klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"29134","DOI":"10.1074\/jbc.M112.342980","article-title":"Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor","volume":"287","author":"Goetz","year":"2012","journal-title":"J Biol Chem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1128\/MCB.06603-11","article-title":"Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands","volume":"32","author":"Goetz","year":"2012","journal-title":"Mol Cell Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature25451","article-title":"alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e0147845","DOI":"10.1371\/journal.pone.0147845","article-title":"Conditional deletion of Fgfr1 in the proximal and distal tubule identifies distinct roles in phosphate and calcium transport","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/Klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"key":"B13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium","volume":"11","author":"Francis","year":"1995","journal-title":"Nat Genet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1677\/joe.1.05989","article-title":"Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets","volume":"183","author":"Bresler","year":"2004","journal-title":"J Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1210\/en.2007-1205","article-title":"Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP","volume":"149","author":"Martin","year":"2008","journal-title":"Endocrinology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1749-6632.1995.tb44629.x","article-title":"Osteopontin and the bone remodeling sequence. Colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein","volume":"760","author":"McKee","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jbmr.1766","article-title":"Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia","volume":"28","author":"Barros","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e104154","DOI":"10.1371\/journal.pone.0104154","article-title":"Osteocyte-specific deletion of Fgfr1 suppresses FGF23","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jbmr.1810","article-title":"Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets","volume":"28","author":"Wohrle","year":"2013","journal-title":"J Bone Miner Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/jbmr.544","article-title":"A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells","volume":"27","author":"Ichikawa","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1210\/en.2016-1642","article-title":"A mutation in the Dmp1 gene alters phosphate responsiveness in mice","volume":"158","author":"Ichikawa","year":"2017","journal-title":"Endocrinology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201ctrade-off\u201d hypothesis","volume":"5","author":"Gutierrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J Bone Miner Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1210\/endo.143.2.8657","article-title":"Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous Klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene","volume":"143","author":"Yoshida","year":"2002","journal-title":"Endocrinology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.matbio.2006.10.003","article-title":"Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice","volume":"26","author":"Hesse","year":"2007","journal-title":"Matrix Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e31376","DOI":"10.1371\/journal.pone.0031376","article-title":"Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo","volume":"7","author":"Anour","year":"2012","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1210\/en.2011-1878","article-title":"Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor","volume":"153","author":"Streicher","year":"2012","journal-title":"Endocrinology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","article-title":"A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis","volume":"90","author":"Araya","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse Klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","article-title":"A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis","volume":"117","author":"Ichikawa","year":"2007","journal-title":"J Clin Invest"},{"key":"B35","doi-asserted-by":"publisher","first-page":"F282","DOI":"10.1152\/ajprenal.90742.2008","article-title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","volume":"297","author":"Gattineni","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.bone.2012.05.015","article-title":"FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1\/2-SGK1 signaling pathway","volume":"51","author":"Andrukhova","year":"2012","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"E508","DOI":"10.1152\/ajpendo.00499.2010","article-title":"Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype","volume":"300","author":"Li","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1210\/en.2011-1831","article-title":"Chronic inhibition of ERK1\/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice","volume":"153","author":"Zhang","year":"2012","journal-title":"Endocrinology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/jbmr.401","article-title":"Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice","volume":"26","author":"Ranch","year":"2011","journal-title":"J Bone Miner Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"17541","DOI":"10.1074\/jbc.M117.806901","article-title":"A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation","volume":"292","author":"Meyer","year":"2017","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.abb.2011.11.003","article-title":"25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D","volume":"523","author":"Jones","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"B44","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1042\/BJ20041799","article-title":"Role of the vitamin D receptor in FGF23 action on phosphate metabolism","volume":"390","author":"Inoue","year":"2005","journal-title":"Biochem J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"C159","DOI":"10.1152\/ajpcell.00456.2004","article-title":"Parathyroid hormone treatment induces dissociation of type IIa Na+-P(i) cotransporter-Na+\/H+ exchanger regulatory factor-1 complexes","volume":"289","author":"Deliot","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1172\/JCI32738","article-title":"Parathyroid hormone inhibits renal phosphate transport by phosphorylation of serine 77 of sodium-hydrogen exchanger regulatory factor-1","volume":"117","author":"Weinman","year":"2007","journal-title":"J Clin Invest"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jbmr.3195","article-title":"Klotho lacks a FGF23 independent role in mineral homeostasis","volume":"32","author":"Andrukhova","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B48","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/embj.201284188","article-title":"FGF23 promotes renal calcium reabsorption through the TRPV5 channel","volume":"33","author":"Andrukhova","year":"2014","journal-title":"EMBO J"},{"key":"B49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.mce.2016.07.035","article-title":"Fgf23 and parathyroid hormone signaling interact in kidney and bone","volume":"436","author":"Andrukhova","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1681\/ASN.2008080873","article-title":"Parathyroid hormone activates TRPV5 via PKA-dependent phosphorylation","volume":"20","author":"de Groot","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1210\/jc.2004-0724","article-title":"FGF-23 is elevated by chronic hyperphosphatemia","volume":"89","author":"Gupta","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1359\/jbmr.070304","article-title":"Cinacalcet in the management of tumor-induced osteomalacia","volume":"22","author":"Geller","year":"2007","journal-title":"J Bone Miner Res"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1172\/JCI61405","article-title":"FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality","volume":"122","author":"Shalhoub","year":"2012","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00220","article-title":"X-linked hypophosphatemia and FGF23-related hypophosphatemic diseases \u2013 prospect for new treatment","author":"Kinoshita","year":"2018","journal-title":"Endocr Rev"},{"key":"B56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jbmr.2606","article-title":"FGF23 regulates bone mineralization in a 1,25(OH) D and Klotho-independent manner","volume":"31","author":"Murali","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"15872","DOI":"10.1074\/jbc.M701116200","article-title":"Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity","volume":"282","author":"Addison","year":"2007","journal-title":"J Biol Chem"},{"key":"B58","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","article-title":"Fibroblast growth factor 23 (FGF23) and alpha-Klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization","volume":"89","author":"Shalhoub","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e93840","DOI":"10.1371\/journal.pone.0093840","article-title":"Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice","volume":"9","author":"Miyagawa","year":"2014","journal-title":"PLoS One"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1002427","DOI":"10.1371\/journal.pbio.1002427","article-title":"Excessive osteocytic Fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in hyp mice","volume":"14","author":"Murali","year":"2016","journal-title":"PLoS Biol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","article-title":"FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis","volume":"289","author":"Coe","year":"2014","journal-title":"J Biol Chem"},{"key":"B62","doi-asserted-by":"publisher","first-page":"fj201700667R","DOI":"10.1096\/fj.201700667R","article-title":"Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia","author":"Agoro","year":"2018","journal-title":"FASEB J"},{"key":"B63","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.13585","article-title":"Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density","volume":"137","author":"Hensel","year":"2016","journal-title":"J Neurochem"},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","article-title":"Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion","volume":"9","author":"Olauson","year":"2013","journal-title":"PLoS Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.1172\/JCI32409","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"key":"B69","doi-asserted-by":"publisher","first-page":"11298","DOI":"10.1038\/s41598-017-10140-4","article-title":"Genetic ablation of Fgf23 or Klotho does not modulate experimental heart hypertrophy induced by pressure overload","volume":"7","author":"Slavic","year":"2017","journal-title":"Sci Rep"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00267\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,28]],"date-time":"2018-05-28T04:17:58Z","timestamp":1527481078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2018.00267\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,28]]},"references-count":69,"alternative-id":["10.3389\/fendo.2018.00267"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00267","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,28]]},"article-number":"267"}}